High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma.
High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma.
复制标题
DOI：
10.1038/bcj.2017.94
复制
发表时间：
2017-09-22
影响因子：
12.8
通讯作者：
Stewart AK
中科院分区：
文献类型：
--
作者：
Miller A;Asmann Y;Cattaneo L;Braggio E;Keats J;Auclair D;Lonial S;MMRF CoMMpass Network;Russell SJ;Stewart AK
Tumor-specific mutations can result in immunogenic neoantigens, both of which have been correlated with responsiveness to immune checkpoint inhibitors in highly mutagenic cancers. However, early results of single-agent checkpoint inhibitors in multiple myeloma (MM) have been underwhelming. Therefore, we sought to understand the relationship between mutation and neoantigen landscape of MM patients and responsiveness to therapies. Somatic mutation burden, neoantigen load, and response to therapy were determined using interim data from the MMRF CoMMpass study (NCT01454297) on 664 MM patients. In this population, the mean somatic and missense mutation loads were 405.84(s=608.55) and 63.90(s=95.88) mutations per patient, respectively. There was a positive linear relationship between mutation and neoantigen burdens (R2=0.862). The average predicted neoantigen load was 23.52(s=52.14) neoantigens with an average of 9.40(s=26.97) expressed neoantigens. Survival analysis revealed significantly shorter progression-free survival (PFS) in patients with greater than average somatic missense mutation load (N=163, 0.493 vs 0.726 2-year PFS, P=0.0023) and predicted expressed neoantigen load (N=214, 0.555 vs 0.729 2-year PFS, P=0.0028). This pattern is maintained when stratified by disease stage and cytogenetic abnormalities. Therefore, high mutation and neoantigen load are clinically relevant risk factors that negatively impact survival of MM patients under current standards of care.
登录
查看更多内容
新抗原的预测和优先排序：RNA 测序数据与全外显子组测序的整合。
影响因子：
5.7
作者：
Karasaki T;Nagayama K;Kuwano H;Nitadori JI;Sato M;Anraku M;Hosoi A;Matsushita H;Takazawa M;Ohara O;Nakajima J;Kakimi K
通讯作者：
Kakimi K
影响因子：
50.3
作者：
Braggio E;Kortüm KM;Stewart AK
通讯作者：
Stewart AK
DOI：
10.1093/bioinformatics/btu638
发表时间：
2015-01-15
期刊：
Bioinformatics (Oxford, England)
影响因子：
--
作者：
Anders S;Pyl PT;Huber W
通讯作者：
Huber W
DOI：
10.1038/nrc3239
发表时间：
2012-03-22
期刊：
Nature reviews. Cancer
影响因子：
--
作者：
Pardoll DM
通讯作者：
Pardoll DM
影响因子：
11.4
作者：
通讯作者：
--